Stockreport

LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA® [Yahoo! Finance]

LAVA Therapeutics N.V. - Ordinary Shares  (LVTX) 
PDF Enrollment will continue in the monotherapy and IL-2 combination arms of the study LAVA Therapeutics N.V. Nasdaq: LVTX ), today announced that it has entered into a c [Read more]